Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis.
Saved in:
| Title: | Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis. |
|---|---|
| Authors: | Rubbert-Roth, Andrea1, Aletaha, Daniel2, Devenport, Jenny3, Sidiropoulos, Paris N4, Luder, Yves5, Edwardes, Michael D6, Jacobs, Johannes W G7 j.w.g.jacobs-12@umcutrecht.nl |
| Source: | Rheumatology. Feb2021, Vol. 60 Issue 2, p682-691. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14620324 |
|---|---|
| DOI: | 10.1093/rheumatology/keaa259 |